Lauren Elisabeth Wisk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lauren Elisabeth Wisk has a total of 296 co-authors. Here are the top co-authors by number of shared publications:
- Elissa R. Weitzman
Department of Pediatrics, Harvard Medical School, Boston, USA
10 shared publications Elissa R. Weitzman
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts; Computational Health Informatics Program, Boston Children's Hospital, Boston, Massachusetts
9 shared publications- Whitney P. Witt
Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin, Madison
7 shared publications - Estelle Everett
University of California, Los Angeles, USA
6 shared publications - Fathima Wakeel
College of Health, Lehigh University, Bethlehem, USA
6 shared publications - Kara M. Magane
School of Public Health, Boston University, Boston, MA, United States
5 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e102008
Exploring Social Media Use and Anxiety Symptoms in Health Care Workers During the COVID-19 Pandemic: Cross-Sectional Secondary Data Analysis
Background: Health care workers (HCWs) experienced significant mental health challenges, particularly anxiety, during the COVID-19 pandemic. Although social media became a primary source of information and connection, it was also a potential source of stress. The influence of social media on HCWs’ anxiety is not well understood. Objective: This study examined associations between social media use and anxiety symptoms among HCWs during the COVID-19 pandemic. Methods: We conducted a secondary, cross-sectional analysis of data from the 2021 UC-COVID study (N=427 HCWs). Anxiety symptoms were assessed using the Generalized Anxiety Disorder-2 (GAD-2). Social media use across multiple platforms (Twitter, Facebook, Instagram, other social media platforms, and other media sources) was evaluated using factor analysis to create a single variable for social media use. Logistic regression models estimated associations between overall social media use and anxiety symptoms, both unadjusted and adjusted for demographic, occupational, and health-related characteristics. Results: Factor analysis supported a single latent factor representing overall social media use, with all platform indicators loading significantly on the factor ( P <.001) and with moderate loadings (0.33‐0.59). Of 427 HCWs, the mean age was 44.3 (SD 13.5), and the majority identified as female (n=314, 73.5%) and as working in a hospital location (n=136, 43.6%). Facebook was used the most, with 54% (n=230) of participants using the platform at least once per day. A total of 29% reported clinically relevant anxiety symptoms (GAD-2 ≥3). Using the social media variable from the factor analysis, higher social media use was significantly associated with anxiety symptoms (odds ratio [OR] 1.77, CI 1.15‐2.73). Older age was significantly associated with reduced anxiety symptoms (adjusted odds ratio [aOR] 0.97, CI 0.95‐0.99). HCWs with a history of mental health diagnoses reported higher levels of anxiety symptoms (aOR 2.33, CI 1.35‐4.03). Non-Hispanic Asian HCWs reported fewer anxiety symptoms compared to Non-Hispanic White HCWs (aOR 0.39, CI 0.19‐0.80). Participants reporting higher income had significantly lower odds of anxiety symptoms than those in the lower-income group (aOR 0.51, CI 0.30‐0.87). Conclusions: Study findings highlight the multifactorial nature of anxiety symptoms in HCWs and the need to consider social media use as an important contributor. Integrating HCWs and multiplatform social media use into a single measure offered an innovative lens on digital behavior and anxiety symptoms. The rapidly evolving digital landscape underscores the need for continued research. Future studies should include emerging social media platforms (ie, TikTok, Reddit, YouTube) as usage patterns shift over time. Longitudinal and mixed methods approaches are necessary to understand patterns and methods of social media use over time. Larger and more diverse HCW samples, stronger mental health measures (eg, GAD-7, depression, and burnout scales), and analyses stratified by clinical role and sociodemographic factors will be essential to guide interventions supporting mental health and well-being.
- 15 October 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e102008
Open AccessExploring Social Media Use and Anxiety Symptoms in Health Care Workers During the COVID-19 Pandemic: Cross-Sectional Secondary Data Analysis
Background: Health care workers (HCWs) experienced significant mental health challenges, particularly anxiety, during the COVID-19 pandemic. Although social media became a primary source of information and connection, it was also a potential source of stress. The influence of social media on HCWs’ anxiety is not well understood. Objective: This study examined associations between social media use and anxiety symptoms among HCWs during the COVID-19 pandemic. Methods: We conducted a secondary, cross-sectional analysis of data from the 2021 UC-COVID study (N=427 HCWs). Anxiety symptoms were assessed using the Generalized Anxiety Disorder-2 (GAD-2). Social media use across multiple platforms (Twitter, Facebook, Instagram, other social media platforms, and other media sources) was evaluated using factor analysis to create a single variable for social media use. Logistic regression models estimated associations between overall social media use and anxiety symptoms, both unadjusted and adjusted for demographic, occupational, and health-related characteristics. Results: Factor analysis supported a single latent factor representing overall social media use, with all platform indicators loading significantly on the factor ( P <.001) and with moderate loadings (0.33‐0.59). Of 427 HCWs, the mean age was 44.3 (SD 13.5), and the majority identified as female (n=314, 73.5%) and as working in a hospital location (n=136, 43.6%). Facebook was used the most, with 54% (n=230) of participants using the platform at least once per day. A total of 29% reported clinically relevant anxiety symptoms (GAD-2 ≥3). Using the social media variable from the factor analysis, higher social media use was significantly associated with anxiety symptoms (odds ratio [OR] 1.77, CI 1.15‐2.73). Older age was significantly associated with reduced anxiety symptoms (adjusted odds ratio [aOR] 0.97, CI 0.95‐0.99). HCWs with a history of mental health diagnoses reported higher levels of anxiety symptoms (aOR 2.33, CI 1.35‐4.03). Non-Hispanic Asian HCWs reported fewer anxiety symptoms compared to Non-Hispanic White HCWs (aOR 0.39, CI 0.19‐0.80). Participants reporting higher income had significantly lower odds of anxiety symptoms than those in the lower-income group (aOR 0.51, CI 0.30‐0.87). Conclusions: Study findings highlight the multifactorial nature of anxiety symptoms in HCWs and the need to consider social media use as an important contributor. Integrating HCWs and multiplatform social media use into a single measure offered an innovative lens on digital behavior and anxiety symptoms. The rapidly evolving digital landscape underscores the need for continued research. Future studies should include emerging social media platforms (ie, TikTok, Reddit, YouTube) as usage patterns shift over time. Longitudinal and mixed methods approaches are necessary to understand patterns and methods of social media use over time. Larger and more diverse HCW samples, stronger mental health measures (eg, GAD-7, depression, and burnout scales), and analyses stratified by clinical role and sociodemographic factors will be essential to guide interventions supporting mental health and well-being.
- Open Access
- 13 August 2026
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 11, e97122
The Emotional Burden and Behavioral Impacts of Alarms and Alerts Across the Spectrum of Diabetes Technology Use: a Cross-Sectional Study
Background: Continuous glucose monitors (CGMs), sensor-augmented pumps (SAPs), and automated insulin delivery (AID) systems have substantially improved glycemic outcomes for people with type 1 diabetes (T1D). However, these technologies also generate frequent alarms and alerts that may contribute to emotional burden, alarm fatigue, and maladaptive behavioral responses. Despite increasing recognition of alarm-related distress, little is known about how alarm burden differs across contemporary diabetes technologies. Objective: This study evaluated differences in alarm frequency, emotional burden, and behavioral responses to alarms and alerts among adults using CGMs alone, SAP therapy, and AID systems. Methods: We conducted a cross-sectional survey of adults (≥18 years) with T1D receiving care within a large academic health system between August 2024 and March 2025. Eligible participants completed an online survey assessing demographics, diabetes technology use, perceptions of alarm frequency and burden, and responses to alarms and alerts. Participants were categorized as CGM-only, SAP, or AID users. Differences between groups were evaluated using χ 2 tests and ANOVA. Ordinal logistic regression models adjusted for age, gender, and diabetes duration were used to examine associations between diabetes technology type and alarm-related outcomes. Results: Among 838 respondents (mean age 46.0, SD 16.6 years; mean diabetes duration 23.0, SD 14.0 years; n=457, 55% women), AID users reported the highest alarm frequency, with 49% (252) experiencing alarms several times daily, compared with 35% (28) of SAP users and 32% (79) of CGM-only users ( P <.001). AID users also reported greater alarm disruptiveness, annoyance, and unwanted attention than CGM-only users. Overcorrection of glucose levels in response to alerts was common across all technologies: 44% (371) and 50% (419) of participants reported sometimes overcorrecting low and high glucose levels, respectively, while 32% (265) and 18% (147) reported often or always overcorrecting low and high glucose levels, respectively. After adjustment, AID users had greater odds of frequent alarms (odds ratio [OR] 1.98, 95% CI 1.48-2.65), alarm disruptiveness (OR 1.67, 95% CI 1.24-2.25), annoyance (OR 1.65, 95% CI 1.23-2.19), unwanted attention (OR 1.85, 95% CI 1.38-2.47), ignoring alarms (OR 1.86, 95% CI 1.40-2.47), and overcorrecting low glucose levels (OR 1.61, 95% CI 1.20-2.15) compared with CGM-only users. Perceived effectiveness of alarms did not differ by technology type. Conclusions: Although AID systems provide important clinical benefits, they are associated with the greatest alarm and alert burden. Alarm-driven behaviors, including ignoring alerts and overcorrecting glucose levels, represent previously underrecognized consequences of diabetes technology that may diminish user experience and potentially affect glycemic management. These findings identify opportunities to improve alert algorithms while highlighting the need for individualized patient education, clinician engagement in setting appropriate alert thresholds, and routine assessment of alarm burden to optimize both glycemic outcomes and patient-centered experiences with diabetes technology.
- 13 August 2026
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 11, e97122
Open AccessThe Emotional Burden and Behavioral Impacts of Alarms and Alerts Across the Spectrum of Diabetes Technology Use: a Cross-Sectional Study
Background: Continuous glucose monitors (CGMs), sensor-augmented pumps (SAPs), and automated insulin delivery (AID) systems have substantially improved glycemic outcomes for people with type 1 diabetes (T1D). However, these technologies also generate frequent alarms and alerts that may contribute to emotional burden, alarm fatigue, and maladaptive behavioral responses. Despite increasing recognition of alarm-related distress, little is known about how alarm burden differs across contemporary diabetes technologies. Objective: This study evaluated differences in alarm frequency, emotional burden, and behavioral responses to alarms and alerts among adults using CGMs alone, SAP therapy, and AID systems. Methods: We conducted a cross-sectional survey of adults (≥18 years) with T1D receiving care within a large academic health system between August 2024 and March 2025. Eligible participants completed an online survey assessing demographics, diabetes technology use, perceptions of alarm frequency and burden, and responses to alarms and alerts. Participants were categorized as CGM-only, SAP, or AID users. Differences between groups were evaluated using χ 2 tests and ANOVA. Ordinal logistic regression models adjusted for age, gender, and diabetes duration were used to examine associations between diabetes technology type and alarm-related outcomes. Results: Among 838 respondents (mean age 46.0, SD 16.6 years; mean diabetes duration 23.0, SD 14.0 years; n=457, 55% women), AID users reported the highest alarm frequency, with 49% (252) experiencing alarms several times daily, compared with 35% (28) of SAP users and 32% (79) of CGM-only users ( P <.001). AID users also reported greater alarm disruptiveness, annoyance, and unwanted attention than CGM-only users. Overcorrection of glucose levels in response to alerts was common across all technologies: 44% (371) and 50% (419) of participants reported sometimes overcorrecting low and high glucose levels, respectively, while 32% (265) and 18% (147) reported often or always overcorrecting low and high glucose levels, respectively. After adjustment, AID users had greater odds of frequent alarms (odds ratio [OR] 1.98, 95% CI 1.48-2.65), alarm disruptiveness (OR 1.67, 95% CI 1.24-2.25), annoyance (OR 1.65, 95% CI 1.23-2.19), unwanted attention (OR 1.85, 95% CI 1.38-2.47), ignoring alarms (OR 1.86, 95% CI 1.40-2.47), and overcorrecting low glucose levels (OR 1.61, 95% CI 1.20-2.15) compared with CGM-only users. Perceived effectiveness of alarms did not differ by technology type. Conclusions: Although AID systems provide important clinical benefits, they are associated with the greatest alarm and alert burden. Alarm-driven behaviors, including ignoring alerts and overcorrecting glucose levels, represent previously underrecognized consequences of diabetes technology that may diminish user experience and potentially affect glycemic management. These findings identify opportunities to improve alert algorithms while highlighting the need for individualized patient education, clinician engagement in setting appropriate alert thresholds, and routine assessment of alarm burden to optimize both glycemic outcomes and patient-centered experiences with diabetes technology.
- Open Access
Identifying social determinants of health subgroups and their associations with health outcomes in a prospective US adult COVID-19 cohort: an analysis of the INSPIRE registry
Objective: To identify subgroups with similar social determinants of health (SDOH) characteristics using latent class analysis (LCA) and examine their associations with physical and mental health, cognitive function and missed workdays at 3 and 6 months post-SARS-CoV-2 infection. We hypothesised that intersecting SDOH factors would differentially influence COVID-19-related health outcomes across subgroups. Design: Prospective cohort study from the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE), with longitudinal data collection and cross-sectional analyses at baseline, 3-month and 6-month follow-ups. Setting: Multicentre registry across eight US academic medical centres (Chicago, Dallas, Houston, Los Angeles, New Haven, Philadelphia, San Francisco and Seattle). Participants: Adults aged ≥18 years, fluent in English or Spanish, with self-reported acute COVID-19 symptoms and a confirmed positive SARS-CoV-2 test within 42 days before enrolment (9 December 2020 to 12 August 2022), and access to an internet-connected device. Exclusions included incarceration, inability to provide informed consent, lack of confirmed SARS-CoV-2 infection or no internet access. Of 3791 eligible participants with complete baseline data, 2897 (76.4%) completed the 3-month follow-up and 2666 (70.3%) completed the 6-month follow-up; most were aged 18–49 years (74–75%), female (66–67%), white (86.6–87.5%) and non-Hispanic (86.6–87.5%). Outcome measures: Prespecified primary outcomes were physical and mental health (Patient-Reported Outcomes Measurement Information System (PROMIS)-29 V.2.1 T-scores for depression, anxiety, fatigue, sleep disturbance, pain interference, physical function and social participation), cognitive function (PROMIS Cognitive Function Short Form 8 T-scores) and missed workdays due to illness (binary: >1 week vs ≤1 week, from a single-item survey). All measures were self-reported and collected at baseline, 3 months and 6 months; no changes from protocol. Results: LCA identified a 4-class model as optimal (lowest Bayesian Information Criterion (BIC) after evaluating 1–7 class models; significant demographic differences (χ 2 p<0.001 for gender, age, race, ethnicity, education and income distributions)). Sensitivity analysis using four age groups (18–29, 30–49, 50–64, ≥65 years) yielded higher BIC (45 430.8) than three groups (18–49, 50–64, ≥65 years; BIC=42 150.9), confirming the primary model. Class 3 (middle-aged, high-income non-Hispanic; n=599 (15.8%)) was the reference group. Compared with Class 3, Class 1 (lower-income, predominantly Hispanic young to middle-aged adults; n=499 (13.2%)) and Class 2 (lower-income, older, predominantly Black non-Hispanic; n=1828 (48.2%)) exhibited significantly worse outcomes across physical and mental health domains (eg, Class 1 3-month anxiety β=4.41 (95% CI 3.25 to 5.56, p<0.001); Class 2 3-month depression β=3.58 (95% CI 2.53 to 4.64, p<0.001)). Classes 1 and 2 also reported significantly worse cognitive function at both time points (eg, Class 1 3-month β=−3.29 (95% CI −4.77 to −1.82, p<0.001)) and Class 2 had significantly higher odds of missed workdays at 6 months (OR=1.853 (95% CI 1.192 to 2.880, p=0.006)). In contrast, Class 4 (young to middle-aged, highly educated, high-income non-Hispanic; n=865 (22.8%)) consistently reported the most favourable outcomes, including better physical function (3-month β=2.04, p<0.001) and lower pain interference compared with the reference group. Conclusions: In this US prospective cohort, SDOH-based subgroups showed persistent disparities in health outcomes post-SARS-CoV-2 infection. Findings highlight the urgent need for intersectional approaches to address systemic inequities in post-COVID-19 recovery. Trial registration number: NCT04610515 .
Open AccessIdentifying social determinants of health subgroups and their associations with health outcomes in a prospective US adult COVID-19 cohort: an analysis of the INSPIRE registry
Objective: To identify subgroups with similar social determinants of health (SDOH) characteristics using latent class analysis (LCA) and examine their associations with physical and mental health, cognitive function and missed workdays at 3 and 6 months post-SARS-CoV-2 infection. We hypothesised that intersecting SDOH factors would differentially influence COVID-19-related health outcomes across subgroups. Design: Prospective cohort study from the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE), with longitudinal data collection and cross-sectional analyses at baseline, 3-month and 6-month follow-ups. Setting: Multicentre registry across eight US academic medical centres (Chicago, Dallas, Houston, Los Angeles, New Haven, Philadelphia, San Francisco and Seattle). Participants: Adults aged ≥18 years, fluent in English or Spanish, with self-reported acute COVID-19 symptoms and a confirmed positive SARS-CoV-2 test within 42 days before enrolment (9 December 2020 to 12 August 2022), and access to an internet-connected device. Exclusions included incarceration, inability to provide informed consent, lack of confirmed SARS-CoV-2 infection or no internet access. Of 3791 eligible participants with complete baseline data, 2897 (76.4%) completed the 3-month follow-up and 2666 (70.3%) completed the 6-month follow-up; most were aged 18–49 years (74–75%), female (66–67%), white (86.6–87.5%) and non-Hispanic (86.6–87.5%). Outcome measures: Prespecified primary outcomes were physical and mental health (Patient-Reported Outcomes Measurement Information System (PROMIS)-29 V.2.1 T-scores for depression, anxiety, fatigue, sleep disturbance, pain interference, physical function and social participation), cognitive function (PROMIS Cognitive Function Short Form 8 T-scores) and missed workdays due to illness (binary: >1 week vs ≤1 week, from a single-item survey). All measures were self-reported and collected at baseline, 3 months and 6 months; no changes from protocol. Results: LCA identified a 4-class model as optimal (lowest Bayesian Information Criterion (BIC) after evaluating 1–7 class models; significant demographic differences (χ 2 p<0.001 for gender, age, race, ethnicity, education and income distributions)). Sensitivity analysis using four age groups (18–29, 30–49, 50–64, ≥65 years) yielded higher BIC (45 430.8) than three groups (18–49, 50–64, ≥65 years; BIC=42 150.9), confirming the primary model. Class 3 (middle-aged, high-income non-Hispanic; n=599 (15.8%)) was the reference group. Compared with Class 3, Class 1 (lower-income, predominantly Hispanic young to middle-aged adults; n=499 (13.2%)) and Class 2 (lower-income, older, predominantly Black non-Hispanic; n=1828 (48.2%)) exhibited significantly worse outcomes across physical and mental health domains (eg, Class 1 3-month anxiety β=4.41 (95% CI 3.25 to 5.56, p<0.001); Class 2 3-month depression β=3.58 (95% CI 2.53 to 4.64, p<0.001)). Classes 1 and 2 also reported significantly worse cognitive function at both time points (eg, Class 1 3-month β=−3.29 (95% CI −4.77 to −1.82, p<0.001)) and Class 2 had significantly higher odds of missed workdays at 6 months (OR=1.853 (95% CI 1.192 to 2.880, p=0.006)). In contrast, Class 4 (young to middle-aged, highly educated, high-income non-Hispanic; n=865 (22.8%)) consistently reported the most favourable outcomes, including better physical function (3-month β=2.04, p<0.001) and lower pain interference compared with the reference group. Conclusions: In this US prospective cohort, SDOH-based subgroups showed persistent disparities in health outcomes post-SARS-CoV-2 infection. Findings highlight the urgent need for intersectional approaches to address systemic inequities in post-COVID-19 recovery. Trial registration number: NCT04610515 .
- Open Access
- 21 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Exploring the Impact of Social Media Use on Anxiety Symptoms in Healthcare Workers during the COVID-19 Pandemic (Preprint)
BACKGROUND Healthcare workers experienced significant mental health challenges, particularly anxiety, during the COVID-19 pandemic. Although social media became a primary source of information and connection, it was also a potential source of stress. The influence of social media on healthcare workers’ anxiety is not well-understood. OBJECTIVE This study examined associations between social media use and anxiety symptoms among healthcare workers during the COVID-19 pandemic. METHODS This study examined associations between social media use and anxiety symptoms among healthcare workers during the COVID-19 pandemic. Methods: We conducted a cross-sectional analysis of data from the 2021 UC COVID study (N=427 healthcare workers). Anxiety symptoms were assessed using the Generalized Anxiety Disorder-2 (GAD-2). Social media use across five platforms (Twitter, Facebook, Instagram, other social media platforms, and other media sources) was evaluated using confirmatory factor analysis within a structural equation modeling framework. The confirmatory factor analysis supported a single latent factor representing overall social media use, with all platform indicators loading significantly (p=<0.01) with moderate loadings (0.33–0.59). Model fit was acceptable (χ²(5)=12.49, p=<0.01), indicating that the five observed variables coherently reflected a unified social media use construct. Logistic regression models estimated associations between overall social media use and anxiety symptoms, both unadjusted and adjusted for demographic, occupational, and health-related characteristics. RESULTS Of the 427 healthcare workers, Facebook was utilized the most with 54% of respondents utilizing the platform at least once a day. A total of 29% reported clinically relevant anxiety symptoms (GAD-2 ≥ 3). Overall, higher social media use was significantly associated with anxiety symptoms (OR=1.77, CI: 1.15-2.73). Older age was significantly associated with lessened anxiety symptoms (aOR=0.97, CI: 0.95–0.99). Healthcare workers with a history of mental health diagnoses reported higher levels of anxiety symptoms (aOR=2.38, CI: 1.38–4.09). Non-Hispanic, non-White healthcare workers reported fewer anxiety symptoms compared to White healthcare workers (aOR=0.49, CI: 0.27–0.91). Participants reporting higher income had significantly lower odds of anxiety symptoms than those in the lower-income group (aOR = 0.38, CI: 0.18–0.81). CONCLUSIONS Social media use during the pandemic was associated with elevated anxiety symptoms among healthcare workers. However, the rapidly evolving digital landscape underscores the need for continued research. Future studies should include emerging social media sources (i.e., TikTok, Reddit, YouTube, etc.) and repeat factor analyses as digital behaviors shift over time. Longitudinal and mixed-methods approaches are necessary to understand patterns and methods of social media use, accounting for misinformation and disinformation, emotional involvement, and content types such as photos and videos. Larger and more diverse healthcare worker samples, stronger mental health measures (e.g., GAD-7, depression, and burnout scales), and analyses stratified by clinical role and work environment will be essential to guide interventions that support healthcare worker well-being in a post-pandemic era with new challenges.
- 21 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessExploring the Impact of Social Media Use on Anxiety Symptoms in Healthcare Workers during the COVID-19 Pandemic (Preprint)
BACKGROUND Healthcare workers experienced significant mental health challenges, particularly anxiety, during the COVID-19 pandemic. Although social media became a primary source of information and connection, it was also a potential source of stress. The influence of social media on healthcare workers’ anxiety is not well-understood. OBJECTIVE This study examined associations between social media use and anxiety symptoms among healthcare workers during the COVID-19 pandemic. METHODS This study examined associations between social media use and anxiety symptoms among healthcare workers during the COVID-19 pandemic. Methods: We conducted a cross-sectional analysis of data from the 2021 UC COVID study (N=427 healthcare workers). Anxiety symptoms were assessed using the Generalized Anxiety Disorder-2 (GAD-2). Social media use across five platforms (Twitter, Facebook, Instagram, other social media platforms, and other media sources) was evaluated using confirmatory factor analysis within a structural equation modeling framework. The confirmatory factor analysis supported a single latent factor representing overall social media use, with all platform indicators loading significantly (p=<0.01) with moderate loadings (0.33–0.59). Model fit was acceptable (χ²(5)=12.49, p=<0.01), indicating that the five observed variables coherently reflected a unified social media use construct. Logistic regression models estimated associations between overall social media use and anxiety symptoms, both unadjusted and adjusted for demographic, occupational, and health-related characteristics. RESULTS Of the 427 healthcare workers, Facebook was utilized the most with 54% of respondents utilizing the platform at least once a day. A total of 29% reported clinically relevant anxiety symptoms (GAD-2 ≥ 3). Overall, higher social media use was significantly associated with anxiety symptoms (OR=1.77, CI: 1.15-2.73). Older age was significantly associated with lessened anxiety symptoms (aOR=0.97, CI: 0.95–0.99). Healthcare workers with a history of mental health diagnoses reported higher levels of anxiety symptoms (aOR=2.38, CI: 1.38–4.09). Non-Hispanic, non-White healthcare workers reported fewer anxiety symptoms compared to White healthcare workers (aOR=0.49, CI: 0.27–0.91). Participants reporting higher income had significantly lower odds of anxiety symptoms than those in the lower-income group (aOR = 0.38, CI: 0.18–0.81). CONCLUSIONS Social media use during the pandemic was associated with elevated anxiety symptoms among healthcare workers. However, the rapidly evolving digital landscape underscores the need for continued research. Future studies should include emerging social media sources (i.e., TikTok, Reddit, YouTube, etc.) and repeat factor analyses as digital behaviors shift over time. Longitudinal and mixed-methods approaches are necessary to understand patterns and methods of social media use, accounting for misinformation and disinformation, emotional involvement, and content types such as photos and videos. Larger and more diverse healthcare worker samples, stronger mental health measures (e.g., GAD-7, depression, and burnout scales), and analyses stratified by clinical role and work environment will be essential to guide interventions that support healthcare worker well-being in a post-pandemic era with new challenges.
- 2 April 2026
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 41 (11) , 3213-3242
Preventive Health Services in Reproductive-Aged Women with Diabetes Mellitus: A Scoping Review
Diabetes mellitus (DM), both type 1 (T1DM) and type 2 (T2DM), complicates about 1% of pregnancies in the US. Current research frequently focuses on the effects of DM on pregnancy outcomes, overlooking the opportunity to examine a woman's health prior to pregnancy despite the significance of pre-conception health on pregnancy outcomes. Recognizing the importance of a woman's overall health, and not just the period in which a woman is pregnant, we set out to explore whether women with DM received recommended preventive health services at the same rates as women without DM. PubMed, Web of Science Core Collection, and Cochrane Library of Systematic Reviews and Trials were searched using search terms related to four areas of preventive health services for women with T1DM or T2DM: contraceptive counseling, age-appropriate cancer screening, pre-conception counseling, and recommended sexually transmitted infection (STI) screening. Most studies confirmed that women with DM consistently received less contraception management or contraception counseling compared to women without DM. Women with DM also had lower rates of breast and cervical cancer screening. Studies of pre-conception counseling suggest low rates of counseling provided to women with DM. No studies comparing STI screening rates between women with and without DM could even be identified. We also identified a paucity of evidence-based interventions directed at expanding the provision of these preventive services to women with DM. Differences exist in the provision of recommended preventive health services between women with and without DM, and there are also research gaps regarding well-woman preventive care in women with DM. Open Science Framework- https://doi.org/10.17605/OSF.IO/3MV6Q.
- 2 April 2026
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 41 (11) , 3213-3242
Preventive Health Services in Reproductive-Aged Women with Diabetes Mellitus: A Scoping Review
Diabetes mellitus (DM), both type 1 (T1DM) and type 2 (T2DM), complicates about 1% of pregnancies in the US. Current research frequently focuses on the effects of DM on pregnancy outcomes, overlooking the opportunity to examine a woman's health prior to pregnancy despite the significance of pre-conception health on pregnancy outcomes. Recognizing the importance of a woman's overall health, and not just the period in which a woman is pregnant, we set out to explore whether women with DM received recommended preventive health services at the same rates as women without DM. PubMed, Web of Science Core Collection, and Cochrane Library of Systematic Reviews and Trials were searched using search terms related to four areas of preventive health services for women with T1DM or T2DM: contraceptive counseling, age-appropriate cancer screening, pre-conception counseling, and recommended sexually transmitted infection (STI) screening. Most studies confirmed that women with DM consistently received less contraception management or contraception counseling compared to women without DM. Women with DM also had lower rates of breast and cervical cancer screening. Studies of pre-conception counseling suggest low rates of counseling provided to women with DM. No studies comparing STI screening rates between women with and without DM could even be identified. We also identified a paucity of evidence-based interventions directed at expanding the provision of these preventive services to women with DM. Differences exist in the provision of recommended preventive health services between women with and without DM, and there are also research gaps regarding well-woman preventive care in women with DM. Open Science Framework- https://doi.org/10.17605/OSF.IO/3MV6Q.
- Open Access
Type 2 Diabetes Risk Perception and Health Behaviors Among Women with History of Gestational Diabetes Mellitus: A Retrospective Analysis
Background/Objectives: History of gestational diabetes mellitus (GDM) is a strong risk factor in the development of type 2 diabetes (T2D). We sought to examine the association between perceived risk of developing T2D and relevant health behaviors in this population. Methods: We analyzed self-reported survey items and objective electronic health record data of participants in the Gestational diabetes Risk Attenuation for New Diabetes (GRAND) Study, a multisite randomized control trial testing the effectiveness of shared decision-making for women with elevated body mass index (BMI), prediabetes and history of GDM. Data on demographics, health behaviors, and perceived T2D risk were self-reported. We ran four regression models to study the association between women’s perceived risk of developing T2D and four key health behaviors: (1) physical activity, (2) consumption of sugar-sweetened beverages, (3) consumption of ultra-processed foods, and (4) consumption of meals prepared outside the home. All models were adjusted for age, race, ethnicity, income, HbA1c, BMI, family history of T2D, and study arm. Results: Our sample included 242 women who on average were 41 years old (±6 years) with BMI of 32.7 (±6.9 kg/m2). Perceived risk of developing T2D was not significantly associated with physical activity, consumption of sugar-sweetened beverages, ultra-processed food consumption, or meals prepared outside of the home. Higher BMI was significantly associated with increased consumption of sugar-sweetened beverages (OR 1.05, 95% CI 1.01–1.10), but not other health behaviors. Conclusions: We found perceived risk of developing T2D was not independently associated with four key health behaviors. Women with GDM are at high risk of developing T2D and may benefit from tailored or more intensive strategies promoting health behavior changes shown to lower T2D risk.
Open AccessType 2 Diabetes Risk Perception and Health Behaviors Among Women with History of Gestational Diabetes Mellitus: A Retrospective Analysis
Background/Objectives: History of gestational diabetes mellitus (GDM) is a strong risk factor in the development of type 2 diabetes (T2D). We sought to examine the association between perceived risk of developing T2D and relevant health behaviors in this population. Methods: We analyzed self-reported survey items and objective electronic health record data of participants in the Gestational diabetes Risk Attenuation for New Diabetes (GRAND) Study, a multisite randomized control trial testing the effectiveness of shared decision-making for women with elevated body mass index (BMI), prediabetes and history of GDM. Data on demographics, health behaviors, and perceived T2D risk were self-reported. We ran four regression models to study the association between women’s perceived risk of developing T2D and four key health behaviors: (1) physical activity, (2) consumption of sugar-sweetened beverages, (3) consumption of ultra-processed foods, and (4) consumption of meals prepared outside the home. All models were adjusted for age, race, ethnicity, income, HbA1c, BMI, family history of T2D, and study arm. Results: Our sample included 242 women who on average were 41 years old (±6 years) with BMI of 32.7 (±6.9 kg/m2). Perceived risk of developing T2D was not significantly associated with physical activity, consumption of sugar-sweetened beverages, ultra-processed food consumption, or meals prepared outside of the home. Higher BMI was significantly associated with increased consumption of sugar-sweetened beverages (OR 1.05, 95% CI 1.01–1.10), but not other health behaviors. Conclusions: We found perceived risk of developing T2D was not independently associated with four key health behaviors. Women with GDM are at high risk of developing T2D and may benefit from tailored or more intensive strategies promoting health behavior changes shown to lower T2D risk.
- 15 October 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (4) , e52
Opioid use patterns and persistent use after hemodialysis access surgery
- 15 October 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (4) , e52
Opioid use patterns and persistent use after hemodialysis access surgery
- 1 September 2025
- Published by American Psychological Association (APA) in Families, Systems, & Health
- Vol. 43 (3) , 550-553
Psychiatric mental health nurse practitioners in pediatric primary care: Interprofessional integrated care as a solution to youth mental health challenges.
In this article, the authors assert that a potential solution to mitigate the mental health care workforce shortage is to embed psychiatric nurses in primary care. Nurse practitioners (NPs) are nurses who have advanced education (master's or doctoral degree) and advanced clinical training to diagnose and treat illness, manage chronic disease, and contribute to population health. Although there are not yet large-scale studies of psychiatric NP integration in primary care, emerging evidence suggests that such models can improve mental health care referrals, increase uptake of mental health referrals, decrease child behavioral symptoms, and decrease repeat primary care visits for unmet behavioral health needs. The ongoing shortage of specialty mental health care providers has created a significant opportunity for physician-nurse collaborative models of care to fill this gap. An innovative and practical solution to the nation's child mental health crisis is expanding, incentivizing, and sustaining the role of psychiatric NPs in pediatric primary care models. Such models may yield distinct health benefits in underserved and low-resource communities with mental health provider shortages. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
- 1 September 2025
- Published by American Psychological Association (APA) in Families, Systems, & Health
- Vol. 43 (3) , 550-553
Psychiatric mental health nurse practitioners in pediatric primary care: Interprofessional integrated care as a solution to youth mental health challenges.
In this article, the authors assert that a potential solution to mitigate the mental health care workforce shortage is to embed psychiatric nurses in primary care. Nurse practitioners (NPs) are nurses who have advanced education (master's or doctoral degree) and advanced clinical training to diagnose and treat illness, manage chronic disease, and contribute to population health. Although there are not yet large-scale studies of psychiatric NP integration in primary care, emerging evidence suggests that such models can improve mental health care referrals, increase uptake of mental health referrals, decrease child behavioral symptoms, and decrease repeat primary care visits for unmet behavioral health needs. The ongoing shortage of specialty mental health care providers has created a significant opportunity for physician-nurse collaborative models of care to fill this gap. An innovative and practical solution to the nation's child mental health crisis is expanding, incentivizing, and sustaining the role of psychiatric NPs in pediatric primary care models. Such models may yield distinct health benefits in underserved and low-resource communities with mental health provider shortages. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
- Open Access
- 1 August 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (8) , e2526506
Variability in Long COVID Definitions and Validation of Published Prevalence Rates
Importance: Long COVID definitions vary widely, and no consensus exists on how to accurately measure its prevalence, complicating both clinical care and research.Objective: To assess long COVID prevalence using various definitions from published literature.Design, Setting, and Participants: This prospective, multicenter cohort study used data from the longitudinal Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE). Participants aged 18 years or older with symptoms suggestive of COVID-19 illness at the time of their index SARS-CoV-2 test enrolled at 8 sites across the US from December 11, 2020, through August 29, 2022, with follow-up surveys collected through February 28, 2023.Exposure: Positive or negative SARS-CoV-2 test result at the time of acute symptoms.Main Outcomes and Measures: Long COVID prevalence among INSPIRE participants with a positive vs negative index SARS-CoV-2 test, based on long COVID definitions in published literature. Secondary outcomes were sensitivity and specificity of published definitions compared with self-reported long COVID.Results: A total of 4575 INSPIRE participants were included (mean [SD] age, 40.40 [14.58] years). Most were female (3013 of 4448 [67.7%]) and aged 18 to 49 years (3338 of 4541 [73.5%]). Applying 5 published definitions for long COVID yielded a prevalence that ranged from 30.84% (95% CI, 29.33%-32.40%) to 42.01% (95% CI, 40.37%-43.66%) at 3 months and 14.23% (95% CI, 13.01%-15.55%) to 21.94% (95% CI, 20.47%-23.47%) at 6 months postinfection; in the 5 comparator studies, reported prevalence of long COVID at 1 to 5 months postinfection ranged from 2.6% (≥84 days) to 47.4% (3-5 months) and at 6 or more months postinfection ranged from 10.0% (95% CI, 8.8%-11.0%) to 61.9% (6-11 months). Using participants’ self-reported long COVID as a criterion standard, existing published definitions had low-to-moderate sensitivity (up to 66.32% [95% CI, 62.59%-69.90%] at 3 months and 45.53% [95% CI, 41.51%-49.60%] at 6 months) and high specificity (up to 81.29% [95% CI, 79.32%-83.15%] at 3 months and 94.26% [95% CI, 92.98%-95.37%]) at 6 months.Conclusions and Relevance: In this cohort study, variability in long COVID prevalence across published definitions highlights the need for a standardized, validated definition to improve clinical recognition and research comparability, ultimately guiding more accurate diagnosis and treatment strategies.
- 1 August 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (8) , e2526506
Open AccessVariability in Long COVID Definitions and Validation of Published Prevalence Rates
Importance: Long COVID definitions vary widely, and no consensus exists on how to accurately measure its prevalence, complicating both clinical care and research.Objective: To assess long COVID prevalence using various definitions from published literature.Design, Setting, and Participants: This prospective, multicenter cohort study used data from the longitudinal Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE). Participants aged 18 years or older with symptoms suggestive of COVID-19 illness at the time of their index SARS-CoV-2 test enrolled at 8 sites across the US from December 11, 2020, through August 29, 2022, with follow-up surveys collected through February 28, 2023.Exposure: Positive or negative SARS-CoV-2 test result at the time of acute symptoms.Main Outcomes and Measures: Long COVID prevalence among INSPIRE participants with a positive vs negative index SARS-CoV-2 test, based on long COVID definitions in published literature. Secondary outcomes were sensitivity and specificity of published definitions compared with self-reported long COVID.Results: A total of 4575 INSPIRE participants were included (mean [SD] age, 40.40 [14.58] years). Most were female (3013 of 4448 [67.7%]) and aged 18 to 49 years (3338 of 4541 [73.5%]). Applying 5 published definitions for long COVID yielded a prevalence that ranged from 30.84% (95% CI, 29.33%-32.40%) to 42.01% (95% CI, 40.37%-43.66%) at 3 months and 14.23% (95% CI, 13.01%-15.55%) to 21.94% (95% CI, 20.47%-23.47%) at 6 months postinfection; in the 5 comparator studies, reported prevalence of long COVID at 1 to 5 months postinfection ranged from 2.6% (≥84 days) to 47.4% (3-5 months) and at 6 or more months postinfection ranged from 10.0% (95% CI, 8.8%-11.0%) to 61.9% (6-11 months). Using participants’ self-reported long COVID as a criterion standard, existing published definitions had low-to-moderate sensitivity (up to 66.32% [95% CI, 62.59%-69.90%] at 3 months and 45.53% [95% CI, 41.51%-49.60%] at 6 months) and high specificity (up to 81.29% [95% CI, 79.32%-83.15%] at 3 months and 94.26% [95% CI, 92.98%-95.37%]) at 6 months.Conclusions and Relevance: In this cohort study, variability in long COVID prevalence across published definitions highlights the need for a standardized, validated definition to improve clinical recognition and research comparability, ultimately guiding more accurate diagnosis and treatment strategies.
- Open Access
- 18 June 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , 416-426
The Effect of SARS-CoV-2 Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE)
Background: The clinical consequences of repeated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not clear, especially as they relate to long-term symptoms after infection. We analyzed data collected for the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) to determine whether reinfection changes the likelihood of symptoms 3–6 months after reinfection compared with the likelihood in individuals experiencing a single infection. Methods: Individuals reporting a single SARS-CoV-2 infection or a single reinfection were included in this analysis. A positive SARS-CoV-2 test occurring ≥90 days after a first infection was considered a reinfection. Outcomes included severe fatigue (fatigue severity score ≥25) and the presence of organ system symptoms 3–6 months after the last infection. Results: The analysis included 886 individuals, 415 (46.8%) of whom experienced reinfection. For individuals who experienced their first infections in either the pre-Delta or Delta periods, the odds of having ≥3 symptoms 3–6 months after their most recent infection was lower in those reinfected than those with a single infection (weighted adjusted odds ratio, 0.45 [95% confidence interval, .21–.95] and 0.51 [.32–.79], respectively). However, in individuals reporting their first infection during the Omicron wave, the odds of reporting ≥3 symptoms after the most recent infection was higher in those reinfected than in those with a single infection (weighted adjusted odds ratio, 1.54 [95% confidence interval, 1.02–2.34]). Conclusions: The timing of initial infection, reinfection, and the variants involved may play important roles in longer-term clinical outcomes. Repeated infection with Omicron variants may increase the risk of long-term symptoms.
- 18 June 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , 416-426
Open AccessThe Effect of SARS-CoV-2 Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE)
Background: The clinical consequences of repeated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not clear, especially as they relate to long-term symptoms after infection. We analyzed data collected for the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) to determine whether reinfection changes the likelihood of symptoms 3–6 months after reinfection compared with the likelihood in individuals experiencing a single infection. Methods: Individuals reporting a single SARS-CoV-2 infection or a single reinfection were included in this analysis. A positive SARS-CoV-2 test occurring ≥90 days after a first infection was considered a reinfection. Outcomes included severe fatigue (fatigue severity score ≥25) and the presence of organ system symptoms 3–6 months after the last infection. Results: The analysis included 886 individuals, 415 (46.8%) of whom experienced reinfection. For individuals who experienced their first infections in either the pre-Delta or Delta periods, the odds of having ≥3 symptoms 3–6 months after their most recent infection was lower in those reinfected than those with a single infection (weighted adjusted odds ratio, 0.45 [95% confidence interval, .21–.95] and 0.51 [.32–.79], respectively). However, in individuals reporting their first infection during the Omicron wave, the odds of reporting ≥3 symptoms after the most recent infection was higher in those reinfected than in those with a single infection (weighted adjusted odds ratio, 1.54 [95% confidence interval, 1.02–2.34]). Conclusions: The timing of initial infection, reinfection, and the variants involved may play important roles in longer-term clinical outcomes. Repeated infection with Omicron variants may increase the risk of long-term symptoms.